Biodexa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Biodexa Pharmaceuticals has a total shareholder equity of £5.3M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £8.0M and £2.7M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£5.23m |
| Equity | UK£5.30m |
| Total liabilities | UK£2.66m |
| Total assets | UK£7.96m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5MP0's short term assets (£7.3M) exceed its short term liabilities (£2.3M).
Long Term Liabilities: 5MP0's short term assets (£7.3M) exceed its long term liabilities (£380.0K).
Debt to Equity History and Analysis
Debt Level: 5MP0 is debt free.
Reducing Debt: 5MP0 has no debt compared to 5 years ago when its debt to equity ratio was 28.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5MP0 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 5MP0 has less than a year of cash runway if free cash flow continues to grow at historical rates of 16.5% each year.